Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-positive lung cancer
Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-positive lung cancer
Key topics from day 2 of the 10th International Workshop on Non-Hodgkin's Lymphoma
Highlights from the 17th International Conference on Cancer Nursing
ASCO / ONS Chemotherapy Standards
Best practice in nurse-led chemotherapy, standardising services, as well as electronic prescriptions and nurse-physician communication
Training for outpatient treatment procedures
Molecular stratification of breast cancer: reaching the clinic
An improving outlook for liver cancer patients
Epithelial mesenchyme transition in cancer cells
Strategies to improve the tolerability of treatment in patients with multiple myeloma
Emerging advances in multiple myeloma; expert roundtable at MM CTP 2012
Best treatment for chronic lymphocytic leukaemia with 17p deletion